Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion type Assertion NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_head.
- NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion description "[These observations make EGFR-inhibiting drugs a logical approach for trials in recurrent GBM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_provenance.
- NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion evidence source_evidence_literature NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_provenance.
- NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion SIO_000772 19204207 NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_provenance.
- NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion wasDerivedFrom befree-20140225 NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_provenance.
- NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_assertion wasGeneratedBy ECO_0000203 NP191358.RAwTeQXAeqKK9ds04k5nrBoXTTcBzITlhtoB-sC3LCBLk130_provenance.